What Researchers Did
Researchers investigated the effects of intermittent hypobaric hypoxia (IHH) on plasma lipid concentrations in 46 male coronary heart disease (CHD) patients.
What They Found
Total cholesterol decreased by 7% immediately after IHH and 9% at 3 months, with HDL levels increasing by 12% at 3 months. LDL levels declined by 13% at 3 months and 11% at 6 months, and the coefficient of atherogenicity (CA) decreased by 26% after treatment and 37% at 3 months, with effects lasting up to 6 months.
What This Means for Canadian Patients
Intermittent hypobaric hypoxia may offer a potential non-pharmacological strategy for improving lipid profiles in male coronary heart disease patients. This could lead to reduced cardiovascular risk, though further research is needed to determine its practical application and accessibility for Canadian patients.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or participants.
Study Limitations
The study's limitations include its relatively small sample size of 46 male patients and the specific nature of the intermittent hypobaric hypoxia intervention.